Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ATP-sensitive potassium (K(ATP)) channels, so named because they are inhibited by intracellular (ATP), play key physiological roles in many tissues. In pancreatic beta cells, these channels regulate glucose-dependent insulin secretion and serve as the target for sulfonylurea drugs used to treat type 2 diabetes. This review focuses on insulin secretory disorders, such as congenital hyperinsulinemia and neonatal diabetes, that result from mutations in K(ATP) channel genes. It also considers the extent to which defective regulation of K(ATP) channel activity contributes to the etiology of type 2 diabetes.

Original publication

DOI

10.1172/JCI25495

Type

Journal article

Journal

J Clin Invest

Publication Date

08/2005

Volume

115

Pages

2047 - 2058

Keywords

ATP-Binding Cassette Transporters, Animals, Diabetes Mellitus, Type 2, Humans, Hyperinsulinism, Insulin, Islets of Langerhans, KATP Channels, Potassium Channels, Inwardly Rectifying, Sulfonylurea Compounds